Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis

Author:

Hill Quentin A.1,Rawstron Andy C.1,de Tute Ruth M.1,Owen Roger G.1

Affiliation:

1. HMDS Laboratory and Department of Haematology, St James’s Institute of Oncology, Leeds, United Kingdom

Abstract

Key Points Occult marrow disease is demonstrable in 68% of patients with solitary plasmacytoma of bone and is predictive of progression. Trials of adjuvant systemic therapy are warranted in high-risk patients.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Reference20 articles.

1. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.;International Myeloma Working Group;Br J Haematol,2003

2. Guidelines on the diagnosis and management of solitary plasmacytoma of bone, extramedullary plasmacytoma and multiple solitary plasmacytomas: 2009 update.http://www.bcshguidelines.com/documents/solitary_plamacytoma_bcsh_FINAL_190109.pdf;Hughes

3. Curability of solitary bone plasmacytoma.;Dimopoulos;J Clin Oncol,1992

4. Immunoglobulin free light chains and solitary plasmacytoma of bone.;Dingli;Blood,2006

5. Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients.;Ozsahin;Int J Radiat Oncol Biol Phys,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3